Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FACBC PET-CT for Recurrent Prostate Carcinoma
NCT00562315Phase 2Completed
- Start
- Oct 2007
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of fluciclovine f 18 in prostate carcinoma. Primary endpoints: Number of Participants With True Positive Scans Within and Outside the Prostate Bed up to 5 years, Number of Participants With False Positive Scans Within and Outside the Prostate Bed up to 5 years and 3 more. Started Oct 2007; status: completed.
02
Drugs
fluciclovine f 18
03
Conditions
prostate carcinoma
Beyond the preview
Go deeper on NCT00562315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562315.